The ARTNet is a consortium with a focus on the mechanistic bases of acquired resistance to cancer therapies and disease recurrence.

The CDMC will help to integrate, manage, and coordinate the activities and basic/preclinical/translational research initiatives of the ARTNet, as well as facilitate collaborations with closely aligned NCI-sponsored programs and resources. The CDMC will be responsible for administrative, outreach, collaborative, and data management activities as it optimizes the functionality of the ARTNet.